nasdaq

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:01 ET  | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics,…

2 months ago

Jiuzi Holdings, Inc. Announces Up to $30 Million Private Placement for Cryptocurrency Acquisition

HANGZHOU, China, Oct. 2, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; the "Company") today announced that it has entered into…

2 months ago

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ:…

2 months ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 01, 2025 17:20 ET  | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc.…

2 months ago

Quintauris and Everspin Technologies Partner to Advance Dependable RISC-V Solutions for Automotive

MUNICH--(BUSINESS WIRE)--Quintauris, the company founded as a single source to enable compatible RISC-V–based products, and Everspin Technologies, Inc. (NASDAQ: MRAM),…

2 months ago

POET Technologies and Semtech Launch 1.6T Optical Receivers for AI Networks

POET's Optical Interposer platform integrates Semtech FiberEdge® technology to achieve cutting-edge sensitivity and power efficiency at 200G per lane. September…

2 months ago

IBM Commits to Invest 20,000 Hours, an Expected Investment Value of $5,000,000, of Solution Architects and AI Engineers to Advance Datavault AIs Partnership

IBM is Datavault AI’s pathway to unlocking data monetization for the Fortune 100 and governments worldwide.BEAVERTON, Ore.--(BUSINESS WIRE)--Datavault AI Inc.…

2 months ago

Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025

September 26, 2025 16:04 ET  | Source: Maris-Tech Ltd. The company continues to advance AI-powered video streaming and edge computing…

2 months ago

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…

2 months ago

FTNT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces That Fortinet, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fortinet, Inc. (NASDAQ: FTNT) common stock…

2 months ago